{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:02:01Z","timestamp":1794258121343,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mesenchymal stem cell (MSC)-mediated immunomodulation has been harnessed for the treatment of human diseases, but its underlying mechanism has not been fully understood. Dead cells, including apoptotic cells have immunomodulatory properties. It has been repeatedly reported that the proportion of nonviable MSCs in a MSC therapeutic preparation varied from 5~50% in the ongoing clinical trials. It is conceivable that the nonviable cells in a MSC therapeutic preparation may play a role in the therapeutic effects of MSCs. We found that the MSC therapeutic preparation in the present study had about 5% dead MSCs (DMSCs), characterized by apoptotic cells. Namely, 1\u2009\u00d7\u200910\n                    <jats:sup>6<\/jats:sup>\n                    MSCs in the preparation contained about 5\u2009\u00d7\u200910\n                    <jats:sup>4<\/jats:sup>\n                    DMSCs. We found that the treatment with even 5\u2009\u00d7\u200910\n                    <jats:sup>4<\/jats:sup>\n                    DMSCs alone had the equal therapeutic effects as with 1\u2009\u00d7\u200910\n                    <jats:sup>6<\/jats:sup>\n                    MSCs. This protective effect of the dead MSCs alone was confirmed in four mouse models, including concanavalin A (ConA)- and carbon tetrachloride (CCl\n                    <jats:sub>4<\/jats:sub>\n                    )-induced acute liver injury, LPS-induced lung injury and spinal cord injury. We also found that the infused MSCs died by apoptosis in vivo. Furthermore, the therapeutic effect was attributed to the elevated level of phosphatidylserine (PS) upon the injection of MSCs or DMSCs. The direct administration of PS liposomes (PSLs) mimic apoptotic cell fragments also exerted the protective effects as MSCs and DMSCs. The Mer tyrosine kinase (MerTK) deficiency or the knockout of chemokine receptor C\u2013C motif chemokine receptor 2 (CCR2) reversed these protective effects of MSCs or DMSCs. These results revealed that DMSCs alone in the therapeutic stem cell preparation or the apoptotic cells induced in vivo may exert the same immunomodulatory property as the \u201cliving MSCs preparation\u201d through releasing PS, which was further recognized by MerTK and participated in modulating immune cells.\n                  <\/jats:p>","DOI":"10.1038\/s41392-021-00688-z","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T09:05:59Z","timestamp":1626253559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine"],"prefix":"10.1038","volume":"6","author":[{"given":"Xuemei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1668-2301","authenticated-orcid":false,"given":"Weiqi","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3003-8910","authenticated-orcid":false,"given":"Lunzhi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-1895","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2247-7750","authenticated-orcid":false,"given":"Canhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6513-6422","authenticated-orcid":false,"given":"Xiawei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"688_CR1","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1161\/01.CIR.0000163546.27639.AA","volume":"111","author":"M Hofmann","year":"2005","unstructured":"Hofmann, M. et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111, 2198\u20132202 (2005).","journal-title":"Circulation"},{"key":"688_CR2","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.jhep.2015.07.035","volume":"63","author":"KC Lee","year":"2015","unstructured":"Lee, K. C., Lin, H. C., Huang, Y. H. & Hung, S. C. Allo-transplantation of mesenchymal stem cells attenuates hepatic injury through IL1Ra dependent macrophage switch in a mouse model of liver disease. J. Hepatol. 63, 1405\u20131412 (2015).","journal-title":"J. Hepatol."},{"key":"688_CR3","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee, J. S. et al. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28, 1099\u20131106 (2010).","journal-title":"Stem Cells"},{"key":"688_CR4","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1634\/stemcells.2008-0034","volume":"26","author":"A Banas","year":"2008","unstructured":"Banas, A. et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 26, 2705\u20132712 (2008).","journal-title":"Stem Cells"},{"key":"688_CR5","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1164\/rccm.201802-0356OC","volume":"199","author":"D Islam","year":"2019","unstructured":"Islam, D. et al. Identification and modulation of microenvironment is crucial for effective mesenchymal stromal cell therapy in acute lung injury. Am. J. Respir. Crit. Care Med. 199, 1214\u20131224 (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"688_CR6","doi-asserted-by":"publisher","first-page":"6705","DOI":"10.2147\/IJN.S146742","volume":"12","author":"X Duan","year":"2017","unstructured":"Duan, X. et al. The long-term fate of mesenchymal stem cells labeled with magnetic resonance imaging-visible polymersomes in cerebral ischemia. Int. J. Nanomed. 12, 6705\u20136719 (2017).","journal-title":"Int. J. Nanomed."},{"key":"688_CR7","doi-asserted-by":"crossref","unstructured":"Bruder, S. P. et al. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin. Orthop. Relat. Res. S247\u2013S256 (1998).","DOI":"10.1097\/00003086-199810001-00025"},{"key":"688_CR8","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Yamamoto, Y., Xiao, Z. & Ochiya, T. The immunomodulatory functions of mesenchymal stromal\/stem cells mediated via paracrine activity. J. Clin. Med. 8, 1025 (2019).","DOI":"10.3390\/jcm8071025"},{"key":"688_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song, N., Scholtemeijer, M. & Shah, K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol. Sci. 41, 653\u2013664 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"688_CR10","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","volume":"77","author":"XL Fan","year":"2020","unstructured":"Fan, X. L., Zhang, Y., Li, X. & Fu, Q. L. Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol. Life Sci. 77, 2771\u20132794 (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"688_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.94","volume":"45","author":"MB Murphy","year":"2013","unstructured":"Murphy, M. B., Moncivais, K. & Caplan, A. I. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp. Mol. Med. 45, e54 (2013).","journal-title":"Exp. Mol. Med."},{"key":"688_CR12","doi-asserted-by":"publisher","first-page":"9682757","DOI":"10.1155\/2016\/9682757","volume":"2016","author":"L Li","year":"2016","unstructured":"Li, L., Chen, X., Wang, W. E. & Zeng, C. How to improve the survival of transplanted mesenchymal stem cell in ischemic heart? Stem Cells Int. 2016, 9682757 (2016).","journal-title":"Stem Cells Int."},{"key":"688_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.transproceed.2006.12.019","volume":"39","author":"S Schrepfer","year":"2007","unstructured":"Schrepfer, S. et al. Stem cell transplantation: the lung barrier. Transplant. Proc. 39, 573\u2013576 (2007).","journal-title":"Transplant. Proc."},{"key":"688_CR14","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13287-018-1098-4","volume":"9","author":"T Sun","year":"2018","unstructured":"Sun, T. et al. A combination of ultrasound-targeted microbubble destruction with transplantation of bone marrow mesenchymal stem cells promotes recovery of acute liver injury. Stem Cell Res. Ther. 9, 356 (2018).","journal-title":"Stem Cell Res. Ther."},{"key":"688_CR15","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.4103\/1673-5374.233448","volume":"13","author":"BDS Ramalho","year":"2018","unstructured":"Ramalho, B. D. S. et al. Injection of bone marrow mesenchymal stem cells by intravenous or intraperitoneal routes is a viable alternative to spinal cord injury treatment in mice. Neural Regen. Res. 13, 1046\u20131053 (2018).","journal-title":"Neural Regen. Res."},{"key":"688_CR16","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1172\/JCI1112","volume":"101","author":"VA Fadok","year":"1998","unstructured":"Fadok, V. A. et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101, 890\u2013898 (1998).","journal-title":"J. Clin. Invest."},{"key":"688_CR17","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.4049\/jimmunol.1303377","volume":"192","author":"N Ipseiz","year":"2014","unstructured":"Ipseiz, N. et al. The nuclear receptor Nr4a1 mediates anti-inflammatory effects of apoptotic cells. J. Immunol. 192, 4852\u20134858 (2014).","journal-title":"J. Immunol."},{"key":"688_CR18","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1165\/ajrcmb.24.5.4292","volume":"24","author":"K Morimoto","year":"2001","unstructured":"Morimoto, K. et al. Alveolar macrophages that phagocytose apoptotic neutrophils produce hepatocyte growth factor during bacterial pneumonia in mice. Am. J. Respir. Cell Mol. Biol. 24, 608\u2013615 (2001).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"688_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.immuni.2009.06.018","volume":"31","author":"NA Gonzalez","year":"2009","unstructured":"Gonzalez, N. A. et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245\u2013258 (2009).","journal-title":"Immunity"},{"key":"688_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/sj.bjp.0707302","volume":"151","author":"GC Ramos","year":"2007","unstructured":"Ramos, G. C. et al. Apoptotic mimicry: phosphatidylserine liposomes reduce inflammation through activation of peroxisome proliferator-activated receptors (PPARs) in vivo. Br. J. Pharmacol. 151, 844\u2013850 (2007).","journal-title":"Br. J. Pharmacol."},{"key":"688_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.cdd.4400404","volume":"5","author":"VA Fadok","year":"1998","unstructured":"Fadok, V. A. et al. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 5, 551\u2013562 (1998).","journal-title":"Cell Death Differ."},{"key":"688_CR22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/cdd.2016.11","volume":"23","author":"RB Birge","year":"2016","unstructured":"Birge, R. B. et al. Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ. 23, 962\u2013978 (2016).","journal-title":"Cell Death Differ."},{"key":"688_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nprot.2009.238","volume":"5","author":"H Zhu","year":"2010","unstructured":"Zhu, H. et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat. Protoc. 5, 550\u2013560 (2010).","journal-title":"Nat. Protoc."},{"key":"688_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1634\/stemcells.21-5-527","volume":"21","author":"S Sun","year":"2003","unstructured":"Sun, S. et al. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cells 21, 527\u2013535 (2003).","journal-title":"Stem Cells"},{"key":"688_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1128\/MCB.01287-12","volume":"33","author":"H Qian","year":"2013","unstructured":"Qian, H. et al. Molecular characterization of prospectively isolated multipotent mesenchymal progenitors provides new insight into the cellular identity of mesenchymal stem cells in mouse bone marrow. Mol. Cell Biol. 33, 661\u2013677 (2013).","journal-title":"Mol. Cell Biol."},{"key":"688_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-1-59745-060-7_18","volume":"482","author":"M Gnecchi","year":"2009","unstructured":"Gnecchi, M. & Melo, L. G. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol. Biol. 482, 281\u2013294 (2009).","journal-title":"Methods Mol. Biol."},{"key":"688_CR27","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/hep.28682","volume":"64","author":"JC Mossanen","year":"2016","unstructured":"Mossanen, J. C. et al. Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury. Hepatology 64, 1667\u20131682 (2016).","journal-title":"Hepatology"},{"key":"688_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09046-8","volume":"10","author":"W Yang","year":"2019","unstructured":"Yang, W. et al. Neutrophils promote the development of reparative macrophages mediated by ROS to orchestrate liver repair. Nat. Commun. 10, 1076 (2019).","journal-title":"Nat. Commun."},{"key":"688_CR29","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/hep.29544","volume":"67","author":"O Krenkel","year":"2018","unstructured":"Krenkel, O. et al. Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. Hepatology 67, 1270\u20131283 (2018).","journal-title":"Hepatology"},{"key":"688_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4049\/jimmunol.1400574","volume":"193","author":"E Zigmond","year":"2014","unstructured":"Zigmond, E. et al. Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury. J. Immunol. 193, 344\u2013353 (2014).","journal-title":"J. Immunol."},{"key":"688_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jss.2012.04.070","volume":"178","author":"GZ Pan","year":"2012","unstructured":"Pan, G. Z. et al. Bone marrow mesenchymal stem cells ameliorate hepatic ischemia\/reperfusion injuries via inactivation of the MEK\/ERK signaling pathway in rats. J. Surg. Res. 178, 935\u2013948 (2012).","journal-title":"J. Surg. Res."},{"key":"688_CR32","doi-asserted-by":"publisher","first-page":"7283703","DOI":"10.1155\/2018\/7283703","volume":"2018","author":"S Li","year":"2018","unstructured":"Li, S. et al. Mesenchymal stem cells ameliorate hepatic ischemia\/reperfusion injury via inhibition of neutrophil recruitment. J. Immunol. Res. 2018, 7283703 (2018).","journal-title":"J. Immunol. Res."},{"key":"688_CR33","first-page":"29","volume":"60","author":"CJ Bishop","year":"1979","unstructured":"Bishop, C. J. & Donald, K. J. Non-immunological cell death of intravenously injected murine tumour cells. Br. J. Exp. Pathol. 60, 29\u201337 (1979).","journal-title":"Br. J. Exp. Pathol."},{"key":"688_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fimmu.2012.00297","volume":"3","author":"E Eggenhofer","year":"2012","unstructured":"Eggenhofer, E. et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front. Immunol. 3, 297 (2012).","journal-title":"Front. Immunol."},{"key":"688_CR35","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Panes","year":"2016","unstructured":"Panes, J. et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388, 1281\u20131290 (2016).","journal-title":"Lancet"},{"key":"688_CR36","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","volume":"54","author":"JM Hare","year":"2009","unstructured":"Hare, J. M. et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54, 2277\u20132286 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"688_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","volume":"3","author":"JG Wilson","year":"2015","unstructured":"Wilson, J. G. et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir. Med. 3, 24\u201332 (2015).","journal-title":"Lancet Respir. Med."},{"key":"688_CR38","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.4049\/jimmunol.179.3.1855","volume":"179","author":"N Gupta","year":"2007","unstructured":"Gupta, N. et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J. Immunol. 179, 1855\u20131863 (2007).","journal-title":"J. Immunol."},{"key":"688_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4062\/biomolther.2015.085","volume":"23","author":"JY Kim","year":"2015","unstructured":"Kim, J. Y. et al. Pretreatment with lycopene attenuates oxidative stress-induced apoptosis in human mesenchymal stem cells. Biomol. Ther. (Seoul) 23, 517\u2013524 (2015).","journal-title":"Biomol. Ther. (Seoul)"},{"key":"688_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev.biophys.093008.131234","volume":"39","author":"PA Leventis","year":"2010","unstructured":"Leventis, P. A. & Grinstein, S. The distribution and function of phosphatidylserine in cellular membranes. Annu. Rev. Biophys. 39, 407\u2013427 (2010).","journal-title":"Annu. Rev. Biophys."},{"key":"688_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/gutjnl-2016-313615","volume":"67","author":"E Triantafyllou","year":"2018","unstructured":"Triantafyllou, E. et al. MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure. Gut 67, 333\u2013347 (2018).","journal-title":"Gut"},{"key":"688_CR42","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.cmet.2019.11.013","volume":"31","author":"B Cai","year":"2020","unstructured":"Cai, B. et al. Macrophage MerTK promotes liver fibrosis in nonalcoholic steatohepatitis. Cell Metab. 31, 406\u2013421 (2020). e407.","journal-title":"Cell Metab."},{"key":"688_CR43","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.1073\/pnas.1524292113","volume":"113","author":"B Cai","year":"2016","unstructured":"Cai, B. et al. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc. Natl Acad. Sci. USA 113, 6526\u20136531 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"688_CR44","doi-asserted-by":"crossref","unstructured":"Cai, B. et al. MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity. Sci. Signal. 11, eaar3721 (2018).","DOI":"10.1126\/scisignal.aar3721"},{"key":"688_CR45","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3389\/fimmu.2017.01042","volume":"8","author":"F Luk","year":"2017","unstructured":"Luk, F. et al. Inflammatory conditions dictate the effect of mesenchymal stem or stromal cells on B cell function. Front. Immunol. 8, 1042 (2017).","journal-title":"Front. Immunol."},{"key":"688_CR46","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/stem.2254","volume":"34","author":"P Luz-Crawford","year":"2016","unstructured":"Luz-Crawford, P. et al. Mesenchymal stem cell-derived interleukin 1 receptor antagonist promotes macrophage polarization and inhibits B cell differentiation. Stem Cells 34, 483\u2013492 (2016).","journal-title":"Stem Cells"},{"key":"688_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K Nemeth","year":"2009","unstructured":"Nemeth, K. et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42\u201349 (2009).","journal-title":"Nat. Med."},{"key":"688_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep37566","volume":"6","author":"Y Deng","year":"2016","unstructured":"Deng, Y. et al. Umbilical cord-derived mesenchymal stem cells instruct monocytes towards an IL10-producing phenotype by secreting IL6 and HGF. Sci. Rep. 6, 37566 (2016).","journal-title":"Sci. Rep."},{"key":"688_CR49","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-019-1802-2","volume":"577","author":"RJ Vagnozzi","year":"2020","unstructured":"Vagnozzi, R. J. et al. An acute immune response underlies the benefit of cardiac stem cell therapy. Nature 577, 405\u2013409 (2020).","journal-title":"Nature"},{"key":"688_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jhep.2011.03.022","volume":"56","author":"V Volarevic","year":"2012","unstructured":"Volarevic, V. et al. Protective role of IL-33\/ST2 axis in Con A-induced hepatitis. J. Hepatol. 56, 26\u201333 (2012).","journal-title":"J. Hepatol."},{"key":"688_CR51","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1371\/journal.pmed.0040269","volume":"4","author":"SH Mei","year":"2007","unstructured":"Mei, S. H. et al. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 4, e269 (2007).","journal-title":"PLoS Med."},{"key":"688_CR52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/08977150360547099","volume":"20","author":"SW Scheff","year":"2003","unstructured":"Scheff, S. W. et al. Experimental modeling of spinal cord injury: characterization of a force-defined injury device. J. Neurotrauma 20, 179\u2013193 (2003).","journal-title":"J. Neurotrauma"},{"key":"688_CR53","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1089\/neu.2006.23.635","volume":"23","author":"DM Basso","year":"2006","unstructured":"Basso, D. M. et al. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J. Neurotrauma 23, 635\u2013659 (2006).","journal-title":"J. Neurotrauma"},{"key":"688_CR54","doi-asserted-by":"crossref","unstructured":"Liu, L. et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight. 4, e123158 (2019).","DOI":"10.1172\/jci.insight.123158"},{"key":"688_CR55","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1172\/JCI98156","volume":"128","author":"AT Nguyen-Lefebvre","year":"2018","unstructured":"Nguyen-Lefebvre, A. T. et al. The innate immune receptor TREM-1 promotes liver injury and fibrosis. J. Clin. Invest. 128, 4870\u20134883 (2018).","journal-title":"J. Clin. Invest."},{"key":"688_CR56","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.cell.2019.07.050","volume":"178","author":"S Jordan","year":"2019","unstructured":"Jordan, S. et al. Dietary intake regulates the circulating inflammatory monocyte pool. Cell 178, 1102\u20131114 (2019). e1117.","journal-title":"Cell"},{"key":"688_CR57","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.1015623108","volume":"108","author":"T Harel-Adar","year":"2011","unstructured":"Harel-Adar, T. et al. Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair. Proc. Natl Acad. Sci. USA 108, 1827\u20131832 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"}],"updated-by":[{"DOI":"10.1038\/s41392-021-00862-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000}}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00688-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00688-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00688-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T22:03:09Z","timestamp":1675548189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-021-00688-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1038\/s41392-021-00688-z","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]},"assertion":[{"value":"26 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41392-021-00862-3","URL":"https:\/\/doi.org\/10.1038\/s41392-021-00862-3","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no competing interests. C.H. is the editorial board member of Signal Transduction and Targeted Therapy, but he has not been involved in the process of the manuscript handling.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}